What it does
HQ Science is a UK Health Security Agency spin-out commercialising a point-of-care molecular diagnostics platform that combines third-generation sequencing with AI to deliver results within 24 hours at roughly half the cost of current tests. The device is authorised for commercial sale in the UK and registered with the MHRA, has completed a clinical feasibility study with the Oscar Lambret Centre in France, and has signed LOIs with five NHS Trusts and Oscar Lambret. Ready panels include Luminal A/B breast cancer diagnostics and radiological emergency triage, with sepsis in development. The £1.5m EIS seed round funds 24 months of UK and EU commercialisation, ISO 15189 accreditation and rollout across the five NHS Trusts.
